glp 1 drugs depression Most GLP-1 Medications Correlated with a Lower Likelihood of Anxiety and Diagnoses GLP-1 Drugs Linked to 21%

[DOI] [PMC free article] [PubMed] [Google Scholar] 46.Buse J.B., Peters A., Russell-Jones D., Furber S., Donsmark M., Han J

Therefore, impaired autophagy may contribute to the AD pathogenesis (73)

The two biggest long-term concerns are muscle loss and weight rebound after stopping

184,185,186,187 Interactions with other pathways GLP-1 not only promotes the release of insulin but also enhances the response of pancreatic -cells to insulin through the PI3K/Akt pathway, thereby improving insulin signal transduction and increasing the sensitivity of peripheral tissues to insulin

The difference is cost and accessibility, not therapeutic effectiveness

Clinical Trial Evidence: Landmark cardiovascular outcome trials (CVOTs) like the SELECT trial (for semaglutide) have shown a significant reduction in major adverse cardiovascular events (MACE), including heart attack, stroke, and cardiovascular death